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INTRODUCTION
 
Visualization of anatomic and pathological conditions within 
the heart, using noninvasive means, is fundamental for under-
standing, diagnosing, and treating cardiovascular diseases. Car-
diovascular system imaging is technically challenging; it is not 
surprising that cardiovascular applications have often been a 
driving force in the ongoing evolution of imaging technologies.
Atrial fibrillation (AF) is a major independent risk factor for 
stroke, and the risk increases in patients with AF and other con-
comitant potential cardiac sources of embolism [1-4]. Thus, ac-
curate detection and diagnosis of high-risk embolic sources, 
such as cardiac thrombi, is important, as they provide a substrate 
for embolic events and a rationale for anticoagulation therapy. 
For almost 2 decades, the gold standard for assessing flow stasis 
and thrombi in the heart has undoubtedly been echocardiogra-
phy, predominantly transesophageal echocardiography (TEE) 
[5-7]. Intra-cardiac echocardiography (ICE) and TEE evolved 
from transthoracic echocardiography (TTE) as an approach that 
uses high-frequency transducers with improved spatial resolu-
tion. Cardiac computed tomography (CCT) and cardiac mag-
netic resonance imaging (CMRI) have also been proposed and 
tested as alternative imaging modalities for cardiac thrombus 
detection [8-13]. More recently, new imaging techniques, such 
as dual-energy CT (DECT), have been developed and tested to 
assess flow stasis and cardiac thrombi [14].  
In this article, we describe the pathophysiology of thrombus 
formation. We introduce recent technical advances in cardiovas-
cular imaging in the fields of echocardiography, CT, and MRI as 
approaches to evaluate flow stasis and cardiac thrombus. We 
also discuss advantages and disadvantages of the available imag-
ing modalities for cardiac thrombus assessment. 
CaRDIaC ThROmbUs
Laa function and thrombus formation
Anatomically, the left atrial appendage (LAA) is highly vari-
able, and consists of a blind-ended pouch with tapering edges 
and trabeculations from the pectinate muscles. This morphology 
promotes stasis and thrombus formation. The shape of the LAA 
can correlate with different risks of thrombus formation and 
stroke, although this remains controversial; a few studies have 
shown that extensive trabeculations are associated with stroke 
[15,16]. 
Normal contraction of the LAA during sinus rhythm and 
adequate blood flow within the LAA lower the risk for throm-
bus formation within the cavity. Thrombus formation is more 
likely to occur within the LAA in cases with reduced contrac-
tility and stasis. During AF, there is a decrease in LAA contrac-
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tility and function, which manifests as a decrease in Doppler 
velocities and LAA dilatation [17]. The remodeling processes as-
sociated with AF causes the LAA to function as a static pouch, 
predisposing the heart to stagnation and thrombosis. AF results 
in structural remodeling changes in the LAA, especially cham-
ber enlargement. The average LAA volume is more than 3 times 
larger in AF patients, compared with patients in sinus rhythm 
[18]. Other structural LAA changes those in AF include lumi-
nal surface area enlargement, a smoother endocardial surface, 
and a higher degree of endocardial fibroelastosis, all of which 
can all contribute to thrombus formation [18,19].
La or Laa thrombus
The left atrium (LA) and the LAA are important locations 
that are frequently associated with thrombus formation and 
subsequent cardioembolic events, particularly in association 
with dysrhythmias, such as AF [20,21]. An estimated 47% of 
thrombi in valvular AF and 91% of those in nonvalvular AF are 
located in the LAA [22]. Therefore, current research is focused on 
the LAA to better understand its anatomy, physiology, and to test 
various imaging modalities and techniques to assess the shape 
and size, blood flow patterns, and for the presence or absence of 
thrombi. Cardiac thrombi of the LA or LAA are common 
causes of stroke, and because the LA and LAA thrombi are treat-
able sources of embolism, thrombi detection may significantly af-
fect patient management. 
LV thrombus
Left ventricular (LV) thrombi can occur in LV dysfunction, 
especially in the acute stage after myocardial infarction (MI) 
[23,24]. LV thrombi are clinically important because of their 
ability to embolize [25,26]. In fact, patients who develop mural 
thrombi after MI have a poor prognosis, including a 10% rate 
of systemic embolization [27]. Early detection of LV thrombi is 
critical because it allows for early initiation of anticoagulation 
therapy to reduce the likelihood of embolization [28].
Right heart thrombus
Right heart thrombus (RHT) in the absence of structural heart 
disease, atrial fibrillation, or a cardiac catheter is rare. The majori-
ty of thrombi originates from the deep venous system and embo-
lize to the right heart as precursors of a pulmonary embolism 
(PE) [29]. Clinical consequences of RHT depend upon the clot 
size and overall clot burden. Thrombi in the right side of the heart 
may become infected or cause a PE. Sudden cardiovascular col-
lapse is the worst possible outcome if the clot compromises the 
cardiac or pulmonary circulation. The overall mortality rate in 
patients with RHT has been reported as 28% and as high as 
100% in untreated patients [30,31]. It is important to diagnose 
an RHT, because it can embolize at any moment, which would 
then require emergency treatment, and this type of embolism 
is associated with a high mortality rate.
ImagINg mODaLITIes
echocardiography
Initial studies that use TTE have a limited ability for detecting 
LA and LAA thrombus formation [7,32]. However, harmonic 
imaging and the administration of ultrasound contrast agents 
have enhanced the ability of TTE to detect LAA thrombi [33,34]. 
Fig. 1. Images from a 45-year-old man with stroke and atrial fibrillation. (A) 4-chamber TTE image shows no thrombus in the LA. (B) TEE im-
age reveals a small echogenic thrombus (arrow) in the LAA. LA: left atrium, LAA: left atrial appendage, TEE: transesophageal echocardiog-
raphy, TTE: transthoracic echocardiography. 
A  B  
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Because of the superior visualization of posterior structures, 
such as the LA and LAA, compared with TTE, TEE has been 
shown to be effective for assessing thrombi in the LA and LAA 
(Fig. 1) [35,36]. Therefore, TEE is currently the most widely-
used method and is accepted as the reference modality for diag-
nosing and excluding the presence of LAA thrombi. However, 
TEE is a semi-invasive procedure that requires special skills for 
proper execution and interpretation. A prospective study report-
ed 100% sensitivity [95% confidence interval (CI): 74–100%], 
99% specificity (95% CI: 97–99.9%), and 100% negative predic-
tive value (NPV) (217/217), but only an 86% positive predictive 
value (PPV) (12/14) for a population with a 5.2% thrombi preva-
lence [36]. The investigators suggested that this low PPV resulted 
from trabeculations or pectinate muscles in the LAA being mis-
interpreted as thrombi by inexperienced observers. 
One drawback of TEE is that it has limited sensitivity for iden-
tifying small thrombi or thrombi within a side lobe. Thus, the 
absence of LAA thrombus visualization does not always equate 
with the absence of an LAA thrombus. Functional assessment of 
the LAA using Doppler echocardiography is widely-used to bet-
ter assess the LAA and the risk of thromboembolism. LAA blood 
flow velocity measurement allows a more-quantifiable assess-
ment of spontaneous echo contrast (SEC) than grades of severity, 
which are primarily based on echogenicity. Decreasing LAA ve-
locities were strongly associated with increasing grades of SEC 
severity in the LA and LAA, and with embolic events [37].
The use of three-dimensional (3D) TEE imaging is a relative-
ly recent development that improves assessment of LAA anato-
my. Although two-dimensional (2D) TEE provides higher-res-
olution images, because of a better frame rate, 3D TEE allows a 
more comprehensive assessment of the LAA and overcomes 
some of the limitations associated with 2D imaging, such as in-
adequate imaging planes. In addition, 3D TEE provides better 
separation and differentiation between adjacent structures, along 
with a more complete and comprehensive evaluation of the 
LAA, its complex morphology, and the surrounding structures 
[38]. There are still limited data regarding the sensitivity and speci-
ficity of 3D TEE for detecting LAA thrombi. However, 3D TEE 
has become an important tool for guiding therapeutic devices 
into the LAA with recent advances in percutaneous devices for 
LAA closure. 
ICE can be used as an alternative imaging method to TEE to 
assess LAA flow stasis and thrombus formation. ICE can pro-
vide multiple views and detailed LAA imaging which facilitates 
detection of potential thrombi [39,40]. Although ICE is less sen-
sitive than TEE for thrombus detection [41], it can serve as a com-
plementary method, especially when equivocal TEE findings merit 
further evaluation. However, because ICE is an invasive proce-
dure, it is not typically used in daily practice and is mainly re-
served for planned interventional cardiac procedures in a cathe-
terization laboratory setting.
2D TTE was the first imaging modality for visualizing LV 
thrombi [42]. 2D TTE has been reported to have sensitivity rates 
of 92% to 95% and specificity rates of 86% to 88% [43,44]. De-
spite its high diagnostic accuracy, TTE can be technically chal-
lenging, as echocardiographic findings of the LV thrombus may 
be subtle and, consequently, easily missed. The disadvantages of 
TTE include difficulty in discerning the myocardium-thrombus 
interface, limited near-field resolution of the apex, and difficulty 
in obtaining images of the true apex. As a result, small non-pro-
truding mural thrombi may resemble a normal or mildly thick-
ened LV wall, and normal structures, such as papillary muscles, 
anomalous bands, and trabeculae may mimic thrombi. TEE has 
been shown to be better suited than TTE for detecting intra-atrial 
Fig. 2. Image from a 68-year-old man with stroke and myocardial infarction. (A) TTE image shows a suspicious echogenic thrombus (arrow) 
in the LV apex. The thrombus evaluation was difficult because of poor acoustic windows. (B) TTE with contrast agent shows a small throm-
bus (arrow) in the LV apex. TTE: transthoracic echocardiography, LV: left ventricle. 
A  B  
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thrombi, but its value in the diagnosis of LV thrombus has not 
been extensively explored [45,46]. A previous study has shown 
that when TTE and TEE are used to detect or exclude the LV 
thrombus, the results may be inconclusive in as many as 46% 
(87/190) of patients [47]. However, advanced techniques, such 
as harmonic imaging and the use of intravenous echocardio-
graphic contrast agents, may improve the overall diagnostic im-
age quality [48]. Thus, LV echocardiographic contrast agents have 
been used to increase the accuracy of LV thrombus detection, es-
pecially in patients with difficult acoustic windows (Fig. 2).
TTE is usually considered as a screening test for diagnosing 
right heart thrombi. TTE may demonstrate right ventricular 
dysfunction, tricuspid regurgitation, and leftward atrial septal 
bowing in patients with pulmonary thromboemboli. However, 
direct visualization of the thrombus located in the pulmonary 
arteries or entrapped in the right atrium is difficult. In contrast, 
TEE not only detects the thrombus in the heart with higher accu-
racy, it may also allow PE to be diagnosed, and is associated with 
80% sensitivity and 100% specificity in patients with suspected 
massive pulmonary emboli [49]. TEE can also provide informa-
tion about the presence of a right-to-left shunt through a patent 
foramen ovale.
Cardiac computed tomography 
A non-invasive method for identifying intracardiac thrombus 
with high reliability and accuracy, comparable to TEE, would be 
of significant clinical value. CCT is a well-established, but not 
widely-used technique for cardiac thrombus imaging. CCT can 
be used to detect intracardiac thrombus with high diagnostic ac-
curacy (Fig. 3) [8-11,50,51]. A recent meta-analysis demonstrated 
that the overall high accuracy of cardiac CT, compared with TEE, 
can be used to detect LA or LAA thrombus in patients with AF. 
The investigators included 19 studies with a total of 2955 patients 
and found the weighted mean sensitivity and specificity to be 
96% (95% CI: 92–100%) and 92% (95% CI: 91–93%), whereas 
the PPV and NPV were 41% (95% CI: 37–44%) and 99% (95% 
CI: 99–100%), respectively [52]. This is because a pseudo-filling 
defect, such as flow stasis, can also cause an apparent filling defect 
on CT images, thereby mimicking a thrombus. Because CCT 
identifies a cardiac thrombus based on anatomic appearance, it 
can be challenging to differentiate between thrombus and flow 
stasis.
The flow stasis phenomenon appears when LA dysfunction 
causes incomplete mixing of contrast agent and blood. There-
fore, delayed phase scanning would allow for complete mixing 
of contrast agent and blood (Figs. 4 and 5) [53,54]. In a sub-
analysis of 753 patients from a recent meta-analysis with avail-
able delayed imaging data, the PPV increased significantly to 
92%, while maintaining a high NPV of 100% and an overall di-
agnostic accuracy of 99% (95% CI: 98–100%) [52]. These results 
suggest that cardiac CT using delayed imaging is a reasonable 
alternative to TEE to evaluate LAA or LA thrombus and to dif-
ferentiate thrombus from flow stasis.
Although delayed imaging with cardiac CT has excellent sen-
sitivity and specificity for thrombus, it requires rescanning with-
in 1 minute. Since this would double the radiation exposure, pri-
or knowledge of or a high suspicion of LA or LAA thrombus 
would be required before patients would be subjected to this pro-
cedure. Therefore, radiation exposure is a significant disadvan-
tage of cardiac CT for LAA evaluation. However, CT has recent-
Fig. 3. Images from a 62-year-old woman with atrial fibrillation. (A) Axial cardiac CT imaging shows an oval filling defect (arrow) in the LAA. 
(B) TEE imaging demonstrates an oval-shaped echogenic thrombus (arrow) in the LAA. LAA: left atrial appendage, TEE: transesophageal 
echocardiography.
A  B  
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ly undergone technical and acquisition changes that substantially 
reduce the dose of radiation [55]. 
Recent advancement in CT technology enabled DECT to 
generate material-specific images based on the atomic number Z 
and the unique mass attenuation coefficient of a particular mate-
rial at different X-ray energies [56,57]. Material-specific images 
provide qualitative and quantitative information about tissue 
composition and contrast media distribution. The most signifi-
cant contribution of DECT-based material characterization 
comes from the capability to assess iodine distribution by creat-
ing an image that exclusively shows iodine. These iodine-specif-
ic images increase tissue contrast and amplify subtle attenuation 
differences between normal and abnormal tissues, improving 
lesion detection and characterization. The DECT technique 
permits the differentiation of iodine from other materials by 
the material decomposition method [58]. This is valuable for 
differentiating iodine-enhancing lesions, such as flow stasis or 
tumors, from non-enhancing lesions including thrombus (Figs. 
6 and 7). Early experiences with dual-energy CCT for detecting 
thrombi and blood flow stasis in 63 stroke patients demonstrat-
ed that the overall sensitivity and specificity were 97% (95% CI: 
82–100%) and 100% (95% CI: 86–100%), respectively. In addi-
tion, the PPV was 100%, while maintaining a high NPV of 97% 
[14]. This result suggests that DECT has the potential to detect 
LAA thrombus and distinguish thrombus from flow stasis. An-
other study of dual-energy CCT in 37 patients with cardiac mass-
es demonstrated that the iodine concentration could be feasibly 
quantified from DECT data and used to differentiate cardiac myx-
omas from thrombi. Based on these results, the quantified values 
of the mean iodine concentration (mg/mL) were significantly high-
er in cardiac myxomas compared to cardiac thrombi (3.53±0.72 vs. 
1.37±0.31, respectively, p<0.001) [59]. This study also supported 
Fig. 4. Images from a 65-year-old woman with stroke and atrial fibrillation. (A) Axial early-phase cardiac CT imaging shows a triangular filling 
defect (arrow) in the LAA. (B) Axial late-phase cardiac CT imaging shows a round-shaped thrombus (arrow) in the LAA. LAA: left atrial ap-
pendage.
A  B  
Fig. 5. Images from a 41-year-old man with stroke and atrial fibrillation. (A) Axial early-phase cardiac CT image displays a triangular filling 
defect (arrow) in the LAA. (B) Axial late-phase cardiac CT image shows no filling defect (arrow) in the LAA. The defect caused by blood sta-
sis disappeared during late-phase imaging. (C) TEE image demonstrates moderate spontaneous echo contrast (arrow) with no thrombus in 
the LAA. LAA: left atrial appendage, TEE: transesophageal echocardiography.
A  B  C  
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that dual-energy CCT using a quantitative analytic methodology 
can be used to differentiate and characterize iodine-enhancing 
and non-enhancing lesions. 
Prognosis assessment is very important for therapeutic op-
tions and approaches in patients with pulmonary thromboem-
bolism. Several studies reported that patients with RHT and PE 
had worse prognoses than control groups [60,61]. The Interna-
tional Cooperative Pulmonary Embolism Registry demonstrated 
that among patients with acute pulmonary thromboembolism, 
RHT was a marker of worse prognosis in initially apparently sta-
ble patients treated with heparin alone [61]. In this respect, CCT 
can be used to simultaneously diagnose RHT in patients with 
acute pulmonary thromboembolism. However, there are not 
currently any data on contrast media administration or stan-
dard scanning protocols. 
 
Cardiac magnetic resonance imaging 
Important advances have been made in rapid MR imaging 
technology and its application for cardiovascular imaging dur-
ing the past decade. Clinical high-field strength magnets, high-
performance gradient hardware, and ultrafast pulse sequence 
technology are rapidly improving CMR imaging examination. 
CMR imaging can be used to evaluate potential sources of 
emboli, such as LAA thrombi or LV thrombi [62-64]. Several 
studies have reported that CMR has high reproducibility and 
high sensitivity for detecting LAA thrombus, compared to TEE 
[62,63]. Diagnostically, CMR imaging is potentially more ad-
vantageous, compared with echocardiography because of its 
Fig. 6. Images from a 52-year-old man with stroke and thrombus. (A) Axial cardiac CT shows an oval filling detect (arrow) in the LAA. (B) Axi-
al dual-energy CT iodine map reveals a filling defect in the LAA; the mean iodine concentration within the ROI was 0.66 mg/mL. LAA: left 
atrial appendage, ROI: region of interest.
Fig. 7. Images from a 58-year-old man with atrial fibrillation and flow stasis. (A) Axial cardiac CT shows a triangular filling defect (arrow) in 
the LAA. (B) Axial dual-energy CT iodine map reveals a filling defect in the LAA; the mean iodine concentration within the ROI was 3.36 mg/
mL. LAA: left atrial appendage, ROI: region of interest.
A  B  
A  B  
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ability to characterize the myocardium, in addition to providing 
cine imaging (cine-CMR). However, one of the drawbacks of 
CMR is that it is far from an ideal modality as it has limited spa-
tial resolution and susceptibility to slow flow, which can create 
artifact-mimicking, space-occupying lesions. Spatial resolution 
and image contrast between the background and LA and LAA 
wall, as well as slow flow within the LA and LAA, can affect the 
3-dimensional contrast-enhanced CMR thrombus evaluation [63]. 
Imaging artifacts are also commonly encountered in cine-CMR; 
these include breathing motion, flow-related, and inhomogene-
ity artifacts. 
Recent advances in sequence development, combined with the 
ability of paramagnetic contrast agents to enhance the ventricular 
blood pool, provide delayed enhancement (DE)-CMR with a po-
tential advantage for detecting LA or LV thrombi (Fig. 8). DE-
CMR, is widely-used to discern viable from infarcted myocardia, 
and a thrombus can be identified by the absence of contrast en-
hancement. DE-CMR has been validated as an accurate tech-
nique for thrombus detection based on comparisons with patho-
logical findings and clinical embolic events [13,64-66]. Because 
DE-CMR identifies a thrombus based on tissue characteristics 
rather than anatomic appearance, it allows a thrombus to be de-
lineated from the myocardium and chamber cavity irrespective 
of location or morphology. A previous study reported that, 
among LV thrombi detected in 12 patients that used DE-CMR, 
50% (6/12) were not detected by cine-CMR, and 58% (7/12) were 
not detected by echocardiography [13]. Another study reported 
that DE-CMR identified LV thrombi in 7% of subjects (55 pa-
tients), while cine-CMR identified thrombi in only 4.7% (37 
patients). Among the 55 patients with LV thrombi discovered 
using DE-CMR, 44% (24/55) had prior cine-CMR analyses that 
were negative for thrombus [65]. This study validated the ability 
of long inversion time (TI) DE-CMR to detect LV thrombi and 
also showed the superiority of this technique over cine-CMR. 
Fig. 8. Images from a 52-year-old woman with atrial fibrillation and dilated cardiomyopathy. (A) Oblique sagittal reformatted CT imaging 
shows multiple filling defects (arrows) in the RA and LA. (B) A short-axis cine-CMR image, using a balanced steady-state free precession se-
quence, shows multiple masses (arrows) with iso-signal intensity compared to that of the left ventricular myocardium in the RA and LA. (C) 
On short-axis standard DE-CMR [inversion time (TI), 220 msec], the masses showed black signal intensity without delayed enhancement 
(arrows). (D) On short-axis DE-CMR with long DE-CMR (TI, 400 msec), the masses showed black signal intensity without delayed enhance-
ment (arrows). The masses were confirmed as thrombi which were resolved on follow up transesophageal echocardiography after antico-
agulation therapy. RA: right atrium, LA : left atrium, CMR: cardiac magnetic resonance, DE-CMR: delayed enhancement-CMR. 
A  
C  
B  
D  
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Furthermore, the thrombus prevalence increased with worsening 
LV ejection fraction, ischemia etiology, and myocardial scarring. 
Therefore, the established capabilities of CMR imaging in coro-
nary artery disease are of additional value when characterizing 
a suspected thrombus.
A recent meta-analysis compared the diagnostic ability of TTE 
without contrast, TTE with contrast, cine-CMR, and DE-CMR 
to detect LV thrombi [67]. The investigators included 7 studies 
with a total of 803 patients and demonstrated that DE-CMR im-
aging was the most accurate modality for detecting LV thrombi 
(sensitivity 88%, specificity 99%), followed by cine-CMR imag-
ing (sensitivity 58–79%, specificity 99%, accuracy 95%, PPV 93–
95%, NPV 95–96%), contrast TTE (sensitivity 23–61%, specific-
ity 96–99%, accuracy 92%, PPV 93%, NPV 91%), and, finally, 
non-contrast TTE (sensitivity 24–33%, specificity 94–95%, ac-
curacy 82%, PPV 57%, NPV 85%). In this meta-analysis, they 
were not able to demonstrate differential diagnostic accuracy 
among the different modalities because of the small number of 
studies and variable usage of gold standards. 
A recent study evaluated the diagnostic performance of a com-
prehensive multicomponent CMR for assessing LA/LAA throm-
bus in 261 patients with AF that were referred for pulmonary 
vein isolation [68]. Long TI DE-CMR had the best diagnostic ac-
curacy out of the CMR sequences that were investigated (99.2%; 
95% CI: 97.2–99.9%), sensitivity (100%; 95% CI: 66.4–100%), 
specificity (99.2%; 95% CI: 97.2–99.9%), PPV (81.8%; 95% CI: 
48.2–97.7%), and NPV (100%; 95% CI: 98.5–100%). In contrast, 
cine-CMR had the lowest diagnostic accuracy at 91.6% (95% CI: 
87.5–94.6%), sensitivity of 66.7% (95% CI: 29.9–92.5%), speci-
ficity of 92.5% (95% CI: 88.5–95.4%), and a PPV of 24% (95% 
CI: 9.4–45.1%). All of the CMR sequences had a high negative 
predictive value, ranging from 98.7% by cine-CMR to 100% by 
long TI DE-CMR. This was likely because long TI DE-CMR 
provided adequate coverage of the entire LA and LAA and was 
less susceptible to artifacts. Furthermore, the situation of an un-
der filled LAA could also be avoided, as it was performed with a 
single-shot technique in the equilibrium phase, 10 min after 
contrast administration. In addition, due to the rapid acquisi-
tion time of this technique, breath-holding was not required. 
The processes could also be performed in conditions with ir-
regular cardiac rhythm, which is common in patients with AF. 
Myocardial longitudinal relaxation time measurement (T1 
mapping) with gadolinium contrast-enhanced inversion recov-
ery-prepared sequences has emerged as a novel approach for 
noninvasive quantification of myocardial fibrosis. T1 mapping 
consists of quantifying the T1 relaxation time of a tissue, using an-
alytical expressions of image-based signal intensities. A funda-
mental principal of MR imaging is that the signal intensity of 
pixels is based on the relaxation of hydrogen nuclei protons in 
a static magnetic field [69,70]. The T1 relaxation times of two 
tissues vary substantially. Edema, fat infiltration, and fibrosis also 
cause differences in T1 relaxivity. Qualitative sequences rely on 
the use of arbitrary signal intensity scales for T1 and T2 values 
with interpatient and inter-image variability, whereas myocardial 
mapping offers the potential to produce images that have stan-
dardized, reproducible scales, similar to the attenuation values 
used for CT [71,72]. Although T1 mapping is currently expand-
ing as a means for depicting diffuse interstitial fibrosis in a variety 
of cardiac diseases, this technique is rarely used for focal cardiac 
disease. A few studies have investigated the use of T1 or T2 map-
ping for evaluating cardiac masses [73,74]. A recent study com-
pared the post-contrast T1 time derived from T1 mapping using a 
TI scout (Lock-Locker sequence) for 15 tumors and 15 thrombi 
[73]. As expected, the T1 time was significantly shorter in tumors 
than in thrombi (383±84 ms vs. 477±139 ms, p=0.03). When a 
cut-off value of 422 ms was used as a diagnosis of thrombus, the 
sensitivity and specificity were 67% and 80%, respectively, with 
an area under the receiver-operating characteristic curve of 0.73 
(95% CI: 0.54–0.92). Another recent study investigated T1 and 
T2 values in 22 patients with cardiac thrombus. According to their 
data, the native T1 of thrombi was 1037±152 ms (vs. 1032±39 ms 
for myocardium, p=0.88; vs. 1565±88 ms for blood pool, p< 
0.0001). T2 were 74±13 ms (vs. 51±3 ms for myocardium, p< 
0.0001; vs. 170±32 ms for blood pool, p<0.0001) [74].
CMR imaging is advantageous, compared with cardiac CT, 
due to the absence of radiation exposure and the avoidance of 
iodinated contrast media. However, in contrast to CT technolo-
gy, the future of CMR in assessing cardiac thrombi and flow sta-
sis is less certain. Given the noninvasive nature of CMR and the 
lack of ionizing radiation, developing strategies based on this 
modality for detection of cardiac thrombi and flow stasis is of 
great clinical interest.
CONCLUsION
The accurate detection and diagnosis of cardiac thrombi are 
important, as they provide a substrate for embolic events and a 
rationale for anticoagulation therapy. Substantial efforts have 
been made to improve the evaluation of flow stasis and thrombi 
detection. For almost 2 decades, the gold standard for assessing 
flow stasis and thrombus in the heart has undoubtedly been 
echocardiography, predominantly TEE. However, a non-inva-
sive method with high reliability and accuracy comparable to 
TEE that is capable of identifying intra-cardiac thrombus or flow 
stasis would be of significant clinical value. Currently, CCT and 
CMRI have been proposed and tested as alternative imaging 
modalities. Given the noninvasive nature of CCT and CMR, de-
veloping strategies based on these modalities for the detection of 
cardiac thrombi and flow stasis is of great clinical interest. How-
ever, it must be shown that these advanced imaging techniques 
174  CVIA 2017;1(3):166-176
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yield added value in the clinical setting.
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